PHIO PHARMACEUTICALS CORP. Proceeds from Sale of Productive Assets
PHIO PHARMACEUTICALS CORP. (PHIO) reported Proceeds from Sale of Productive Assets of $3.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2026-08-06
- PHIO PHARMACEUTICALS CORP. proceeds from sale of productive assets for the quarter ending 2026-06-30 was $0.00.
- PHIO PHARMACEUTICALS CORP. proceeds from sale of productive assets for the quarter ending 2026-03-31 was $3.00K.
- PHIO PHARMACEUTICALS CORP. proceeds from sale of productive assets for the quarter ending 2025-06-30 was $0.00.
- PHIO PHARMACEUTICALS CORP. proceeds from sale of productive assets for the quarter ending 2025-03-31 was $0.00.
- PHIO PHARMACEUTICALS CORP. proceeds from sale of productive assets for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- PHIO PHARMACEUTICALS CORP. proceeds from sale of productive assets for fiscal 2024 was $9.00K.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 6 month | Proceeds from Sale of Productive Assets 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $3.00K 10-Q · filed 2026-05-07 | ||
| 2025-12-31 | $0.00 10-K · filed 2026-03-05 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | ||
| 2024-12-31 | $9.00K 10-K · filed 2026-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |